±Ç¾Ö¸° Àü¹®ÀÇ, ¡®´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ Çмú»ó¡¯ ¼ö»ó

´º½ºÀÏÀÚ: 2015³â10¿ù21ÀÏ 17½Ã57ºÐ

[º¸°ÇŸÀÓÁî] ±¹³» ÃÖÃÊ ÀÓ»ó°Ë»ç ¼öŹÀü¹®ÀÇ·á±â°ü ³ì½ÊÀÚÀÇ·áÀç´Ü(¿øÀå ÀÌÀºÈñ)Àº Áø´Ü°Ë»çÀÇÇаú ±Ç¾Ö¸° Àü¹®ÀÇ(»çÁø)°¡ ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ Á¦ 56Â÷ Çмú´ëȸ¿¡¼­ ¿ì¼ö¿µ¾î±¸¿¬»óÀ» ¼ö»óÇß´Ù.

±Ç Àü¹®ÀÇ´Â Áö³­ 15ÀϺÎÅÍ 16ÀϱîÁö ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ¿¡¼­ ¿­¸° ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ Á¦ 56Â÷ Çмú´ëȸ¿¡¼­ ¹ßÇ¥ÇÑ ‘Precision and Functional Sensitivity Assessment of Thyroglobulin Assays: Comparison Between Second-generation Roche ECLIA and BRAHAMS RIA’ÀÇ ³í¹®À¸·Î ‘¿ì¼ö¿µ¾î±¸¿¬»ó’À» ¼ö»óÇÏ°Ô µÆ´Ù.

±Ç Àü¹®ÀÇ´Â ³ì½ÊÀÚÀÇ·áÀç´ÜÀÇ Áø´Ü°Ë»çÀÇÇкΠÀü¹®ÀǷμ­ ±×°£ º¸°Çº¹ÁöºÎ Àå°ü ǥâ ¼ö»ó °ú ³í¹® ¹ßÇ¥¸¦ ÅëÇØ °¢Á¾ Çмú»ó ¼ö»ó µî È°¹ßÇÑ ¿¬±¸ È°µ¿À» ÆîÄ¡°í ÀÖ´Ù.

1982³â ¼³¸³µÈ ³ì½ÊÀÚÀÇ·áÀç´ÜÀº ±¹³» ÃÖÃÊÀÇ ÀÓ»ó°Ë»çÀü¹® ¼öŹÀÇ·á±â°üÀ¸·Î Áø´Ü°Ë»çÀÇÇÐÀû °Ë»ç¿Í º´¸®ÇÐÀû °Ë»ç ¸ðµÎ¸¦ ¼öÇàÇÏ°í ÀÖ´Ù.
ÀϹݰ˻çºÎÅÍ ºÐÀÚÀ¯Àü°Ë»ç, Ư¼ö»ýÈ­ÇÐ °Ë»ç µîÀÇ Æ¯¼ö°Ë»ç¿¡ À̸£±â±îÁö ¾à 4000¿©Á¾ÀÇ °Ë»ç¸¦ ¼öÇàÇÏ°í ÀÖÀ¸¸ç ÀÇÇÐÀ¯Àüü¿¬±¸¼Ò, ´ë»çÀÇÇבּ¸¼Ò µîÀ» ¿î¿µÇÏ¸ç ±¹³»¿¡¼­ °¡Àå ¸¹Àº Ư¼ö °Ë»ç¸¦ ½Ç½ÃÇÏ°í ÀÖ´Ù.  

 

 


ÀÌ ´º½ºÅ¬¸®ÇÎÀº BKT´º½º{www.bktimes.net}¿¡¼­ ¹ßÃéµÈ ³»¿ëÀÔ´Ï´Ù.